Jiufeng Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.
Journal: Frontiers in oncology
Published: August 25, 2019
Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients.
Journal: Frontiers in oncology
Published: July 25, 2019
Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study.
Journal: Journal of medical genetics
Published: June 03, 2019
Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma.
Journal: Cancer management and research
Published: November 15, 2018
TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
Journal: International journal of biological sciences
Published: September 05, 2018
Distinctive clinicopathological features of Von Hippel-Lindau-associated hereditary renal cell carcinoma: A single-institution study.
Journal: Oncology letters
Published: August 11, 2018
Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients.
Journal: Journal of medical genetics
Published: June 25, 2018
Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features.
Journal: Clinical genitourinary cancer
Published: April 13, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026